Avalon GloboCare Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $0TTM through 31 Dec 2025
Net Income -$18.3MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 0.0% |
Returns
-155.8%ROE
-74.9%ROA
Balance Sheet Health
Debt / Equity0.11x
Current Ratio0.11x
Net Debt$990.9K
Cash & Equivalents$110K
Dividend
No dividend
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Consumer Health Technology | $0 | View detailsFocuses on the commercialization and distribution of the KetoAir breathalyzer device in North America. Sales launched in 2024 with minimal initial revenue contribution. | |
| Artificial Intelligence Software | $0 | View detailsOperated through Avalon Quantum AI, LLC, following the acquisition of RPM Interactive, Inc. in December 2025. Focuses on developing and commercializing an AI-driven, short-form video generation platform. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.